Dr. Goldschmidt - ASH 2008 - Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma
Hartmut Goldschmidt, MD Universitätsklinikum Heidelberg und Nationales Centrum für Tumorerkrankungen Heidelberg, Germany Member, IMF Board of Scientific Advisors
Be the first to comment